Last reviewed · How we verify
Traditional treatment
At a glance
| Generic name | Traditional treatment |
|---|---|
| Sponsor | Zan Wang |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Early Surgical Intervention of Congenital Hemivertebra in Young Children (NA)
- DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia (PHASE1, PHASE2)
- Healthy Aging Through Time- Restricted Eating in Adults With Overweight/Obesity and Incipient Liver Disease: ENSATI (NA)
- EFFECT OF A LIGHT STIMULATED FOOTSTEPS PATHWAY ON GAIT IN SPASTIC CHILDREN (NA)
- MANUAL THERAPY ON PAIN, DISABILITY AND QUALITY OF LIFE (NA)
- Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma (PHASE1)
- Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms (NA)
- Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Traditional treatment CI brief — competitive landscape report
- Traditional treatment updates RSS · CI watch RSS
- Zan Wang portfolio CI